Joseph W Babiarz, MD - Medicare Urology in Wausau, WI

Joseph W Babiarz, MD is a medicare enrolled "Urology" physician in Wausau, Wisconsin. His current practice location is 3300 Westhill Dr, Wausau, Wisconsin. You can reach out to his office (for appointments etc.) via phone at (715) 847-2605.

Joseph W Babiarz is licensed to practice in Wisconsin (license number 34030-020) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1962446476.

Contact Information

Joseph W Babiarz, MD
3300 Westhill Dr,
Wausau, WI 54401-4710
(715) 847-2605
(715) 847-2604



Physician's Profile

Full NameJoseph W Babiarz
GenderMale
SpecialityUrology
Location3300 Westhill Dr, Wausau, Wisconsin
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1962446476
  • Provider Enumeration Date: 06/15/2006
  • Last Update Date: 07/28/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 4284823634
  • Enrollment ID: I20110114001090

Medical Identifiers

Medical identifiers for Joseph W Babiarz such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1962446476NPI-NPPES
31908500MedicaidWI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology 34030-020 (Wisconsin)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Joseph W Babiarz allows following entities to bill medicare on his behalf.
Entity NameAspirus Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669595294
PECOS PAC ID: 1052223625
Enrollment ID: O20031103000267

News Archive

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.

Scientists identify brain mechanism that drives our appetite for glucose-rich foods

Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.

Mutated IDH1 gene linked to the progression of gliomas

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.

Read more Medical News

› Verified 8 days ago

Entity NameAspirus Wausau Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922321140
PECOS PAC ID: 6406757442
Enrollment ID: O20040114000297

News Archive

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.

Scientists identify brain mechanism that drives our appetite for glucose-rich foods

Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.

Mutated IDH1 gene linked to the progression of gliomas

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.

Read more Medical News

› Verified 8 days ago

Entity NameLanglade Hospital - Hotel Dieu Of St Joseph Of Antigo Wisconsin
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1831251040
PECOS PAC ID: 1557271202
Enrollment ID: O20040212000310

News Archive

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.

Scientists identify brain mechanism that drives our appetite for glucose-rich foods

Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.

Mutated IDH1 gene linked to the progression of gliomas

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.

Read more Medical News

› Verified 8 days ago

Entity NameUrology Specialists Of Wisconsin S.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1831132018
PECOS PAC ID: 2365428950
Enrollment ID: O20040625000044

News Archive

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.

Scientists identify brain mechanism that drives our appetite for glucose-rich foods

Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.

Mutated IDH1 gene linked to the progression of gliomas

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Joseph W Babiarz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Joseph W Babiarz, MD
3300 Westhill Dr,
Wausau, WI 54401-4710

Ph: (715) 847-2605
Joseph W Babiarz, MD
3300 Westhill Dr,
Wausau, WI 54401-4710

Ph: (715) 847-2605

News Archive

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.

Scientists identify brain mechanism that drives our appetite for glucose-rich foods

Scientists have discovered a mechanism in the brain that may drive our appetite for foods rich in glucose and could lead to improved treatments for obesity.

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.

Mutated IDH1 gene linked to the progression of gliomas

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.

Read more News

› Verified 8 days ago


Urology Doctors in Wausau, WI

Kenneth Lowell Day, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 2603 Teal Ave (residence), Wausau, WI 54401
Phone: 715-842-7019    
Laura E Sherrill, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 3300 Westhill Dr, Wausau, WI 54401
Phone: 715-847-2605    Fax: 715-847-2604
Benjamin S Battino, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 3300 Westhill Dr, Wausau, WI 54401
Phone: 715-847-2605    Fax: 715-847-2604
Roy A Brandell, M.D.
Urology
Medicare: Medicare Enrolled
Practice Location: 3300 Westhill Dr, Wausau, WI 54401
Phone: 715-847-2605    Fax: 715-847-2604
Carl J Viviano, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 3300 Westhill Dr, Wausau, WI 54401
Phone: 715-847-2605    Fax: 715-847-2604

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.